Flavio Rocha, Physician-in-Chief, Knight Cancer Institute at Oregon Health and Science University, shared a post on X:
“Delighted to be a part of the ctDNA panel at SSO2026 with colleagues.
Thanks to HPB DSWG.
The rapid evolution and application of the tech will hopefully allow for more tailored tx to improve outcomes and minimize toxicity.”
Other articles featuring Flavio Rocha on OncoDaily.
